Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Sep. 30, 2018
Current assets:    
Cash $ 8,979,183 $ 3,759,509
Accounts receivable, net 2,487,096 3,972,632
Inventory, net 2,698,306 2,302,030
Prepaid expenses and other current assets 1,208,446 1,148,345
Total current assets 15,373,031 11,182,516
Plant and equipment, net 361,998 404,552
Deferred income taxes 8,546,718 8,543,758
Intangible assets, net 20,400,420 20,477,729
Goodwill 6,878,932 6,878,932
Other assets 773,861 965,152
Total assets 52,334,960 48,452,639
Current liabilities:    
Accounts payable 2,103,711 3,226,036
Accrued research and development costs 569,873 981,357
Accrued expenses and other current liabilities 2,076,009 2,450,364
Credit agreement, short-term portion (Note 7) 4,943,543 6,692,718
Unearned revenue 49,095 202,452
Total current liabilities 9,742,231 13,552,927
Credit agreement, long-term portion (Note 7) 2,996,120 2,701,570
Residual royalty agreement (Note 7) 1,702,576 1,753,805
Other liabilities 30,000 30,000
Deferred rent 86,328 88,161
Deferred income taxes 895,862 844,758
Total liabilities 15,453,117 18,971,221
Commitments and contingencies (Note 11)
STOCKHOLDERS' EQUITY    
Preferred stock; no shares issued and outstanding at December 31, 2018 and September 30,2018
Common stock, par value $0.01 per share; 77,000,000 shares authorized, 64,801,517 and 57,468,660 shares issued and 62,617,813 and 55,284,956 shares outstanding at December 31, 2018 and September 30, 2018, respectively 648,015 574,687
Additional paid-in-capital 104,972,401 95,496,506
Accumulated other comprehensive loss (581,519) (581,519)
Accumulated deficit (60,350,449) (58,201,651)
Treasury stock, 2,183,704 shares, at cost (7,806,605) (7,806,605)
Total stockholders' equity 36,881,843 29,481,418
Total liabilities and stockholders' equity $ 52,334,960 $ 48,452,639